Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Masi, G.
3939  Ergebnisse:
?
1

53P Trifluridine/tipiracil plus capecitabine and bevacizuma..:

Ciracì, P. ; Conca, V. ; Moretto, R....
Annals of Oncology.  35 (2024)  - p. S25-S26 , 2024
Link: https://doi.org/10.1016/..
 
?
2

162TiP Phase II study of consolidation treatment with holmi..:

Borelli, B. ; Bargellini, I. ; Carullo, M....
Annals of Oncology.  35 (2024)  - p. S72-S73 , 2024
Link: https://doi.org/10.1016/..
 
?
3

63P FOLFOXIRI/bevacizumab (bev) versus doublets/bev as init..:

Marmorino, F. ; Antoniotti, C. ; Meinert, F.M....
Annals of Oncology.  35 (2024)  - p. S30 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Management of portal hypertension in patients receiving ate..:

Tovoli, F. ; Franceschini, E. ; Vivaldi, C....
Digestive and Liver Disease.  56 (2024)  - p. S87 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Aetiology of hepatocellular carcinoma and response to immun..:

Tovoli, F. ; Chen, R. ; Vivaldi, C....
Digestive and Liver Disease.  56 (2024)  - p. S92-S93 , 2024
Link: https://doi.org/10.1016/..
 
?
6

158TiP Exploiting circulating tumor DNA (ctDNA) to intensif..:

Conca, V. ; Vetere, G. ; Moretto, R....
Annals of Oncology.  35 (2024)  - p. S70 , 2024
Link: https://doi.org/10.1016/..
 
?
7

OC.04.2: EFFECT OF PREOPERATIVE CHEMO-RADIATION ON TUMORINF..:

Negri, F. ; Gnetti, L. ; Campanini, N....
Digestive and Liver Disease.  56 (2024)  - p. S141-S142 , 2024
Link: https://doi.org/10.1016/..
 
?
8

The synergic effect of metformin with atezolizumab/ bevaciz..:

Dalbeni, A. ; Vicardi, M. ; Natola, L.A....
Digestive and Liver Disease.  56 (2024)  - p. S89-S90 , 2024
Link: https://doi.org/10.1016/..
 
?
9

An overview of the evolution of the modeling of reflectomet..:

da Silva, F. ; Heuraux, S. ; Ribeiro, T....
Fusion Engineering and Design.  202 (2024)  - p. 114354 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Characteristics and outcomes of immunotherapy-related liver..:

Celsa, C. ; Cabibbo, G. ; Fulgenzi, C. AM...
Digestive and Liver Disease.  56 (2024)  - p. S76-S78 , 2024
Link: https://doi.org/10.1016/..
 
?
11

The impact of etiology on patterns of progression of advanc..:

Stefanini, B. ; Piscaglia, F. ; Dalbeni, A....
Digestive and Liver Disease.  56 (2024)  - p. S17 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Predicting early recurrence after resection of initially un..:

Moretto, R. ; Germani, M.M. ; Borelli, B....
ESMO Open.  9 (2024)  4 - p. 102991 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Efficacy and safety of atezolizumab/bevacizumab for hepatoc..:

Tovoli, F. ; Vivaldi, C. ; Federico, P....
Digestive and Liver Disease.  56 (2024)  - p. S85-S86 , 2024
Link: https://doi.org/10.1016/..
 
?
14

185P The combined role of patients (pts) gender and disease..:

Cesario, S. ; Genovesi, V. ; Rimini, M....
Annals of Oncology.  35 (2024)  - p. S83 , 2024
Link: https://doi.org/10.1016/..
 
?
15

108P Negative hyperselection and mechanisms of acquired res..:

Conca, V. ; Carullo, M. ; Vignali, P....
Annals of Oncology.  35 (2024)  - p. S50 , 2024
Link: https://doi.org/10.1016/..
 
1-15